Exogenous Plant gma-miR-159a, Identified by miRNA Library Functional Screening, Ameliorated Hepatic Stellate Cell Activation and Inflammation via Inhibiting GSK-3β-Mediated Pathways

Autor: Yu WY, Cai W, Ying HZ, Zhang WY, Zhang HH, Yu CH

Publikováno v: Journal of Inflammation Research, Vol Volume 14, Pp 2157-2172 (2021)

Wen-Ying Yu,1,* Wei Cai,2,* Hua-Zhong Ying,1 Wen-You Zhang,1 Huan-Huan Zhang,1 Chen-Huan Yu1,3,4 1Zhejiang Key Laboratory of Experimental Animal and Safety Evaluation, Zhejiang Academy of Medical Sciences (Hangzhou Medical College), Hangzhou, People�

Externí odkaz: https://doaj.org/article/f2b33d37d67c4898a7bfc430a528b1bb

Postbiotics in colorectal cancer: intervention mechanisms and perspectives.

Autor: Xie W; Key Laboratory of Experimental Animal and Safety Evaluation, Hangzhou Medical College, Hangzhou, China., Zhong YS; Key Laboratory of Experimental Animal and Safety Evaluation, Hangzhou Medical College, Hangzhou, China., Li XJ; Key Laboratory of Experimental Animal and Safety Evaluation, Hangzhou Medical College, Hangzhou, China., Kang YK; Key Laboratory of Experimental Animal and Safety Evaluation, Hangzhou Medical College, Hangzhou, China., Peng QY; Key Laboratory of Experimental Animal and Safety Evaluation, Hangzhou Medical College, Hangzhou, China., Ying HZ; Key Laboratory of Experimental Animal and Safety Evaluation, Hangzhou Medical College, Hangzhou, China.

Publikováno v: Frontiers in microbiology [Front Microbiol] 2024 Feb 21; Vol. 15, pp. 1360225. Date of Electronic Publication: 2024 Feb 21 (Print Publication: 2024).

Rgl-exomiR-7972, a novel plant exosomal microRNA derived from fresh Rehmanniae Radix, ameliorated lipopolysaccharide-induced acute lung injury and gut dysbiosis.

Autor: Qiu FS; Key Laboratory of Experimental Animal and Safety Evaluation, Zhejiang Academy of Medical Sciences (Hangzhou Medical College), Hangzhou Medical College, Hangzhou 310013, China., Wang JF; Department of Pharmacy, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China., Guo MY; Key Laboratory of Experimental Animal and Safety Evaluation, Zhejiang Academy of Medical Sciences (Hangzhou Medical College), Hangzhou Medical College, Hangzhou 310013, China., Li XJ; Key Laboratory of Experimental Animal and Safety Evaluation, Zhejiang Academy of Medical Sciences (Hangzhou Medical College), Hangzhou Medical College, Hangzhou 310013, China., Shi CY; Key Laboratory of Experimental Animal and Safety Evaluation, Zhejiang Academy of Medical Sciences (Hangzhou Medical College), Hangzhou Medical College, Hangzhou 310013, China; Westlake University, Hangzhou 310024, China., Wu F; Key Laboratory of Experimental Animal and Safety Evaluation, Zhejiang Academy of Medical Sciences (Hangzhou Medical College), Hangzhou Medical College, Hangzhou 310013, China., Zhang HH; Key Laboratory of Experimental Animal and Safety Evaluation, Zhejiang Academy of Medical Sciences (Hangzhou Medical College), Hangzhou Medical College, Hangzhou 310013, China., Ying HZ; Key Laboratory of Experimental Animal and Safety Evaluation, Zhejiang Academy of Medical Sciences (Hangzhou Medical College), Hangzhou Medical College, Hangzhou 310013, China. Electronic address: HZYing0101@163.com., Yu CH; Key Laboratory of Experimental Animal and Safety Evaluation, Zhejiang Academy of Medical Sciences (Hangzhou Medical College), Hangzhou Medical College, Hangzhou 310013, China; Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou 310022, China; Institute of Basic Medicine and Cancer, Chinese Academy of Sciences, Hangzhou 310018, China. Electronic address: yuchenhuan2002@ucas.ac.cn.

Publikováno v: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2023 Sep; Vol. 165, pp. 115007. Date of Electronic Publication: 2023 Jun 14.

Cephalosporins-induced intestinal dysbiosis exacerbated pulmonary endothelial barrier disruption in streptococcus pneumoniae-infected mice.

Autor: Wang JF; Key Laboratory of Experimental Animal and Safety Evaluation, Hangzhou Medical College, Hangzhou, China., Shi CY; Key Laboratory of Experimental Animal and Safety Evaluation, Hangzhou Medical College, Hangzhou, China., Ying HZ; Key Laboratory of Experimental Animal and Safety Evaluation, Hangzhou Medical College, Hangzhou, China.

Publikováno v: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2022 Aug 24; Vol. 12, pp. 997368. Date of Electronic Publication: 2022 Aug 24 (Print Publication: 2022).

Naringin suppressed airway inflammation and ameliorated pulmonary endothelial hyperpermeability by upregulating Aquaporin1 in lipopolysaccharide/cigarette smoke-induced mice.

Autor: Zhang HH; School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China; Zhejiang Provincial Laboratory of Experimental Animal's & Nonclinical Laboratory Studies, Hangzhou Medical College, Hangzhou, China., Zhou XJ; School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China., Zhong YS; Zhejiang Provincial Laboratory of Experimental Animal's & Nonclinical Laboratory Studies, Hangzhou Medical College, Hangzhou, China., Ji LT; School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China., Yu WY; Zhejiang Provincial Laboratory of Experimental Animal's & Nonclinical Laboratory Studies, Hangzhou Medical College, Hangzhou, China., Fang J; Zhejiang Provincial Laboratory of Experimental Animal's & Nonclinical Laboratory Studies, Hangzhou Medical College, Hangzhou, China., Ying HZ; Zhejiang Provincial Laboratory of Experimental Animal's & Nonclinical Laboratory Studies, Hangzhou Medical College, Hangzhou, China. Electronic address: yhz0101@126.com., Li CY; School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China. Electronic address: lcyzcmu@sina.com.

Publikováno v: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2022 Jun; Vol. 150, pp. 113035. Date of Electronic Publication: 2022 Apr 28.